Company intelligence / Profile preview

Shenkar

Huzhou, Zhejiang, Chinaen.shenkar.ac.il ↗

Ownership: Private
Development stage: Other

Overview

Huzhou Shenke Biotechnology is a leading provider of standardized and customized quality control solutions for the biopharmaceutical industry. The company supports regulatory filings with FDA, EMA, and NMPA, including Drug Master Files. Its portfolio includes kits and services supporting R&D through production across cell/gene therapies, vaccines, recombinant proteins/antibodies, small molecules, medical devices/implants, with advanced molecular biology techniques such as qPCR/dPCR/ELISA/LC-MS/NGS.

Modalities: Recombinant proteinMonoclonal antibodySmall moleculeCell therapy productsGene therapy productsVaccine
Industry: Molecular Diagnostics

Partnerships

Supported regulatory submissions to FDA/EMA/NMPA for clients but no explicit named partnerships disclosed

Beyond the preview

Go deeper on Shenkar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenkar.

Explore the full profile